Translated title of the contribution: Vigabatrin and psychosis

F. Provini, C. Marini, A. Cerullo, G. Plazzi, M. Amore, N. Zazzeri, P. Tinuper

Research output: Contribution to journalArticlepeer-review


Use of Vigabatrin (GVG) in the treatment of severe refractory epilepsy has been associated with sporadic development of psychosis. Two women with drug-resistant complex partial seizures and no previous history of psychosis developed a psychotic state following GVG treatment, during which they did not present seizures and EEG was improved or normal. The mechanism of this behaviour change is unclear as is the nature of the association between GVG treatment and psychosis.

Translated title of the contributionVigabatrin and psychosis
Original languageItalian
Pages (from-to)73-74
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number86-87
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Vigabatrin and psychosis'. Together they form a unique fingerprint.

Cite this